Other Consolidated Financial Statement Detail (Tables)

3 Months Ended

Mar. 31, 2012

Business [Abstract]

Other income (expense), net

	For the Three Months
	Ended March 31,
(In millions)	2012			2011
Interest income	$	6.5		$	3.7
Interest expense		(7.4	)		(9.2	)
Impairments of investments		(0.5	)		(0.3	)
Gain (loss) on investments, net		11.8			15.0
Foreign exchange gains (losses), net		1.4			(0.4	)
Other, net		3.3			1.2
Total other income (expense), net	$	15.1		$	10.0

Accrued Expenses and Other

	As of		As of
(In millions)	March 31, 2012		December 31, 2011
Revenue-related rebates	$	132.5	$	115.0
Employee compensation and benefits		108.5		176.3
Deferred revenue		96.0		69.6
Collaboration expenses		53.4		44.2
Clinical development expenses		45.7		40.8
Royalties and licensing fees		43.2		47.4
Current portion of contingent consideration		21.0		10.8
Other		160.3		173.1
Total accrued expenses and other	$	660.6	$	677.2